P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,602.70
68 (1.23%)
BSENSE

Nov 20

BSE+NSE Vol: 24.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
1,217.85
-180.33
-14.81%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
1,217.85
-180.33
-14.81%
Raw Material Cost
222.14
607.15
-385.01
-63.41%
Purchase of Finished goods
48.27
42.12
6.15
14.60%
(Increase) / Decrease In Stocks
1.80
-108.09
109.89
101.67%
Employee Cost
171.70
126.75
44.95
35.46%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
277.86
-5.32
-1.91%
Total Expenditure (Excl Depreciation)
716.45
945.79
-229.34
-24.25%
Operating Profit (PBDIT) excl Other Income
321.07
272.06
49.01
18.01%
Other Income
13.34
4.37
8.97
205.26%
Operating Profit (PBDIT)
334.41
276.43
57.98
20.97%
Interest
0.34
30.04
-29.70
-98.87%
Exceptional Items
0.00
-2.79
2.79
100.00%
Gross Profit (PBDT)
334.07
243.60
90.47
37.14%
Depreciation
17.42
76.15
-58.73
-77.12%
Profit Before Tax
316.65
167.45
149.20
89.10%
Tax
84.34
41.46
42.88
103.42%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
125.99
106.32
84.39%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
125.99
106.32
84.39%
Equity Capital
16.60
45.32
-28.72
-63.37%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
22.34%
0.00
8.61%
Gross Profit Margin
32.20%
20.00%
0.00
12.20%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024